Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Erlotinib Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,396Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Accord healthcare

    02 3Alembic Pharmaceuticals Limited

    03 6Apotex Inc

    04 3Astellas Pharma

    05 3Aurobindo Pharma Limited

    06 2Chartwell Pharmaceuticals llc

    07 3Cipla Medpro South Africa

    08 3Eurolab

    09 6F. Hoffmann-La Roche

    10 2Fujian South Pharmaceutical

    11 3Hetero Drugs

    12 3MSN Laboratories

    13 3Natco Pharma

    14 3Natco Pharma (Canada) Inc

    15 2Nishchay Pharmaceuticals Pvt. Ltd.

    16 2Pharmascience Inc.

    17 3Rising Pharmaceuticals Inc

    18 3Shilpa Medicare

    19 3Sun Pharmaceutical Industries Limited

    20 6Teva Pharmaceutical Industries

    21 3Zydus Pharmaceuticals

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Accord healthcare

    United Kingdom
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Accord healthcare

    United Kingdom
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2020-07-02

    Application Number : 211083

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Accord healthcare

    United Kingdom
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Accord healthcare

    United Kingdom
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2020-07-02

    Application Number : 211083

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Accord healthcare

    United Kingdom
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Accord healthcare

    United Kingdom
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2020-07-02

    Application Number : 211083

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Apotex Inc

    Canada
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Apotex Inc

    Canada
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Apotex Inc

    Canada
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Astellas Pharma

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Astellas Pharma

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Astellas Pharma

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Chartwell Pharmaceuticals llc

    U.S.A
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2024-09-13

    Application Number : 203843

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Chartwell Pharmaceuticals llc

    U.S.A
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2024-09-13

    Application Number : 203843

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Hetero Drugs

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Hetero Drugs

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Hetero Drugs

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Natco Pharma

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Natco Pharma

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Natco Pharma

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Rising Pharmaceuticals Inc

    U.S.A
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Rising Pharmaceuticals Inc

    U.S.A
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Rising Pharmaceuticals Inc

    U.S.A
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    21

    Shilpa Medicare

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Shilpa Medicare

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 211960

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    22

    Shilpa Medicare

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Shilpa Medicare

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 211960

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    23

    Shilpa Medicare

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Shilpa Medicare

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 211960

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    24

    Sun Pharmaceutical Industries Limit...

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 210300

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    25

    Sun Pharmaceutical Industries Limit...

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 210300

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    26

    Sun Pharmaceutical Industries Limit...

    India
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 210300

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    27

    Teva Pharmaceutical Industries

    Israel
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2020-11-09

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    28

    Teva Pharmaceutical Industries

    Israel
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2015-08-28

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    29

    Teva Pharmaceutical Industries

    Israel
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2015-08-28

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    30

    Zydus Pharmaceuticals

    U.S.A
    Immuno-Oncology 360
    Not Confirmed
    arrow

    Zydus Pharmaceuticals

    U.S.A
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2020-04-16

    Application Number : 213065

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF